Dialysis Innovation: Preparing for the Next Wave of Home‑Based Care
The shift toward home‑based dialysis is here, and growing home dialysis utilization is happening. Policy changes, including reimbursement models, and the long-studied clinical, psychosocial, and financial benefits of home dialysis are operationalizing a common goal: moving kidney care into the home while improves outcomes and improves costs.
For dialysis clinics, HME providers, and health systems, the question is no longer if this transition will continue, but how prepared they are to support it at scale.
As CMS introduces longer‑term, value‑based frameworks like the 10-year ACO LEAD demonstration and evaluates performance under programs such as Comprehensive Kidney Care Contracting (CKCC), home dialysis infrastructure is becoming a strategic requirement rather than an optional modality.
Why CMS Is Doubling Down on Home‑Based Kidney Care
CMS (via its innovation arm, CMMI) has spent the past several years testing kidney‑focused, value‑based care models designed to improve coordination, slow disease progression, and expand access to home therapies. Results to date point to a consistent trend: when incentives and patient education align, home dialysis adoption increases.
Early evaluation reports of the Kidney Care Choices (KCC) model, which includes the CKCC option, demonstrate improvements in planned dialysis starts, care coordination metrics, and quantifiable increases in home dialysis utilization among participating organizations. Although the effects on cost and quality are still developing, CMS has made it clear that home-based modalities will continue to be a key component of its long-term strategy.
ACO LEAD, the next-generation accountable care model that will be introduced in 2027, makes that approach even more clear. LEAD is a 10-year program with consistent benchmarks that focuses on high-needs, homebound, and rural populations — three groups with significant overlap in dialysis patients.
What ACO LEAD Signals for Dialysis Providers
To be clear, ACO LEAD is not a kidney‑specific model, but its structure sends a clear signal to dialysis stakeholders. Longer performance periods, prospective payments, and greater accountability for total cost of care increase the financial impact of avoidable hospitalizations, delayed starts, and equipment inefficiencies.
For dialysis programs, this means:
Home readiness matters earlier: Organizations will be expected to identify appropriate home dialysis candidates sooner and support smoother transitions.
Operational gaps carry more risk: Delays in equipment availability, training, or service response can directly affect performance.
Care extends beyond the clinic: Home‑based therapies require dependable logistics, maintenance, and clinical alignment across settings.
While LEAD’s focus on stability gives providers time to invest, it also raises expectations for consistency and scalability.
Lessons from CKCC Performance Results
The findings of the CKCC confirm what many dialysis leaders already know: payment incentives can spur change, but only if the application of best operational practices and support keep up.
According to CMS evaluations, CKCC participants had higher rates of optimal ESRD starts and home dialysis utilization, especially when care teams were able to coordinate earlier modality planning and education for aligned CKD populations. The data also indicates that execution is crucial to success. Training capacity, equipment availability, and continued support all affect how sustainably home programs grow.
In practical terms, CKCC draws attention to a prevalent issue: clinical intent frequently surpasses infrastructure. Programs may share philosophical similarities with home dialysis, but they may be limited by capital expenses, maintenance requirements, or inventory restrictions.
Technology Is Advancing and So Are Expectations
Home dialysis technology has evolved to support broader adoption across care settings. Systems designed for portability, simplified workflows, and flexible deployment reduce barriers for both patients and providers. These advances make it easier to expand home programs, but only if they are paired with reliable operational models.
As home dialysis volumes grow, organizations must account for:
Variable census levels driven by patient choice and acuity changes
Maintenance and compliance requirements across dispersed locations
Operational flexibility to accommodate for new starts (including urgent starts) and modality changes
Ownership models can strain budgets and slow response times when demand fluctuates. As a result, many providers are reevaluating how they source and manage dialysis equipment to stay aligned with value‑based goals.
Preparing Your Organization for the Next Phase
Home dialysis is not only a medical choice, but an operational one as well. Progressive organizations are taking proactive measures today to ensure they are prepared to meet the growing demands of programs such as CKCC and ACO LEAD.
Key preparation steps include:
Assess Home Dialysis Readiness: Evaluate how quickly your organization can support a new home dialysis start, from equipment availability to setup and ongoing service. Delays add risk in value‑based environments.
Build Flexibility into Equipment Strategy: As volumes shift, flexibility matters more than fixed ownership. Scalable access to clinically appropriate systems allows programs to respond without overcommitting capital.
Align Operations with Care Teams: Home therapies succeed when logistics support clinical workflows—not when teams are forced to work around equipment constraints.
Plan for Growth, Not Just Compliance: CMS models increasingly reward proactive care. Infrastructure decisions should support expansion, not just minimum requirements.
The Role of Strategic Equipment Partnerships
As home dialysis becomes a core component of kidney care delivery, equipment strategy plays an increasingly important role in performance outcomes. Access to modern systems, responsive service, and predictable costs helps organizations focus on patient care rather than inventory management.
For many providers, rental and lifecycle‑based approaches offer a practical way to balance innovation with financial discipline, especially as value‑based contracts extend over longer time horizons.
Looking Ahead
The next wave of home‑based dialysis will be shaped as much by operations as by policy. CMS has made its direction clear: coordinated, home‑centered care is a priority, and payment models are evolving to support it.
Organizations that invest early in flexible, reliable home dialysis infrastructure will be better positioned to succeed under CKCC today and ACO LEAD tomorrow, all while delivering care that aligns with patient preferences and clinical goals.
If your team is evaluating how to strengthen or scale its home dialysis capabilities, now is the right time to review your operational strategy and ensure it’s ready for what’s next.
Learn more about how Trace Medical supports home dialysis programs with flexible equipment solutions designed for today’s value‑based care environment.